Together, these results suggest that soft vesicles produced by newly disseminated cancer cells in the soft microenvironment of the lung are significantly more effective at producing a CAF-like phenotype in lung fibroblasts via ensuing upregulation of S100 inflammatory signals and ACTA2//VEGFA/VIM (Fig. 5C). The gene discussed is VEGFA; the disease is cancer.